Original Research ARTICLE
The Effects of Methylphenidate on Resting-State Functional Connectivity of the Basal Nucleus of Meynert, Locus Coeruleus, and Ventral Tegmental Area in Healthy Adults
- 1Department of Psychology, Yale University School of Arts and Sciences, New Haven, CT, USA
- 2Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
- 3Interdepartmental Neuroscience Program, Yale University, New Haven, CT, USA
- 4Center for Molecular and Behavioral Neuroscience, Rutgers, NJ, USA
- 5Department of Neurobiology, Yale University School of Medicine, New Haven, CT, USA
Background: Methylphenidate (MPH) influences catecholaminergic signaling. Extant work examined the effects of MPH on the neural circuits of attention and cognitive control, but few studies have investigated the effect of MPH on the brain's resting-state functional connectivity (rsFC).
Methods: In this observational study, we compared rsFC of a group of 24 healthy adults who were administered an oral 45 mg dose of MPH with a group of 24 age and gender matched controls who did not receive MPH. We focused on three seed regions: basal nucleus of Meynert (BNM), locus coeruleus (LC), and ventral tegmental area/substantia nigra, pars compacta (VTA/SNc), each providing cholinergic, noradrenergic and dopaminergic inputs to the cerebral cortex. Images were pre-processed and analyzed as in our recent work (Li et al., 2014; Zhang et al., 2015). We used one-sample t-test to characterize group-specific rsFC of each seed region and two-sample t-test to compare rsFC between groups.
Results: MPH reversed negative connectivity between BNM and precentral gyri. MPH reduced positive connectivity between LC and cerebellum, and induced positive connectivity between LC and right hippocampus. MPH decreased positive VTA/SNc connectivity to the cerebellum and putamen, and reduced negative connectivity to left middle occipital gyrus.
Conclusion: MPH had distinct effects on the rsFC of BNM, LC, and VTA/SNc in healthy adults. These new findings may further our understanding of the role of catecholaminergic signaling in Attention Deficit Hyperactivity Disorder (ADHD) and Parkinson's disease and provide insights into the therapeutic mechanisms of MPH in the treatment of clinical conditions that implicate catecholaminergic dysfunction.
We seek to characterize the effects of methylphenidate (MPH) on resting state functional connectivity (rsFC) in humans. This study expands upon a previous work, which focused on the dorsal striatum and thalamus (Farr et al., 2014a), by describing the effects of MPH on the whole-brain rsFC of the basal nucleus of Meynert (BNM), locus coeruleus (LC), and the ventral tegmental area/substantia nigra pars compacta (VTA/SNc), each providing cholinergic, noradrenergic (NA), and dopaminergic (DA) inputs, respectively, to the cerebral cortex.
Low frequency, “spontaneous” blood oxygenation level dependent (BOLD) signals are spatially organized and provide valuable insights to the functional architecture of the brain (Fair et al., 2007; Fox and Raichle, 2007). Brain regions involved in similar tasks show correlated BOLD responses during rest. This includes functional connectivity between regions associated with sensorimotor processing, language, visual perception (Cordes et al., 2000), memory (Vincent et al., 2006), and attention (Fox et al., 2006a). A simple, sensitive measure of coordinated regional brain activations, rsFC examines how individual voxels are functionally related by increasing or decreasing activity concurrently (Fox and Raichle, 2007). Using this method, we previously delineated functional subdivisions in the medial superior frontal cortex (Zhang et al., 2012), precuneus (Zhang and Li, 2012) and the inferior parietal lobule (Zhang and Li, 2014), and characterized whole-brain functional connectivity of the BNM and VS (Li et al., 2014) as well as the LC and VTA/SNc (Zhang et al., 2015).
The current study focuses on subcortical nuclei that mediate cholinergic and catecholaminergic signaling as these circuits are of great importance to both basic and clinical neuroscience. For instance, although MPH has been used to treat ADHD and other clinical conditions since the 1950s (Lange et al., 2010), research into its mechanism of action and effects on brain function has only recently begun (for review, see Solanto, 1998; Advokat, 2010; Sahakian et al., 2015). We describe the rationale of the study by focusing on the functional anatomy of the cholinergic and catecholaminergic systems and how these neurotransmitter systems are implicated in the pathophysiology of neuropsychiatric conditions.
Basal Nucleus of Meynert (BNM)
The BNM provides cholinergic inputs to the hippocampus, olfactory bulb, amygdala, and all of the neo-cortex (Pearson et al., 1983; Rye et al., 1984; Richardson and DeLong, 1986). Functionally, BNM is associated with memory formation (Richardson and DeLong, 1988), attention, and the regulation of arousal and sleep (Wenk, 1997). Selective inhibition of BNM leads to memory deficits in rats (Voytko et al., 1994; Stoehr et al., 1997; Tian et al., 2004), which are reversible with a cholinergic agonist (Ridley et al., 1986) or catecholamine enzyme inhibitor, suggesting an interaction between the catecholaminergic and cholinergic systems (Khromova et al., 1995).
40% to 76% of BNM neurons are lost (Tagliavini and Pilleri, 1983) and choline acetyltransferase is diminished by 90% (Candy et al., 1983) in Alzheimer's disease (AD). Given the efficacy of cholinergic treatments (Wilson et al., 1995; Bodick et al., 1997; Rogers et al., 1998; Tariot et al., 2000), the loss of BNM volume likely underlies cognitive dysfunction in AD. Patients with Parkinson's disease (PD) demonstrated a concurrent decrease in choline acetyltransferase in the neocortex and in the number of BNM neurons (Perry et al., 1985). Further, studies have linked cholinergic deficits to catecholaminergic dysfunction in these degenerative conditions. In AD, acetylcholine depletion correlates with NA (Yates et al., 1983) as well as DA and serotoninergic (Reinikainen et al., 1990) depletion.
The interaction of catecholaminergic and cholinergic systems is also evident in other animal studies (Janowsky et al., 1974; Tellez et al., 1999; Cucchiaro and Commons, 2003). Rats treated with MPH exhibit stereotyped gnawing behavior, which can be reduced with physostigmine, a cholinesterase inhibitor, both pre- and post-treatment (Janowksy et al., 1972). A similar antagonistic relationship between the two drugs was found in human schizophrenia and mania patients, with physostigmine and MPH each enhancing and impeding behavioral inhibition (Janowsky et al., 1973). While it is not clear where in the neural circuits these interactions transpire, the BNM receives direct projections from the VTA/SNc (Gaykema and Zaborszky, 1996) and modulates nigrostriatal circuit activity (Haber and Knutson, 2009). It is plausible that the DA and cholinergic systems have cascading interactions at multiple levels of representations. By addressing the effect of MPH on the cerebral functional connectivity of the BNM, the present study would provide some information on this issue.
Locus Coeruleus (LC)
LC is the largest source of NA neurons in the central nervous system (CNS) (Moore and Bloom, 1979; Foote et al., 1983), supporting arousal and cognitive functioning (Berridge and Waterhouse, 2003; Aston-Jones and Cohen, 2005). Phasic LC activation quickly follows presentation of target stimuli, precedes the delivery of associated reward, and expresses an anticipation signal (Aston-Jones et al., 1985, 1994), with concurrent norepinephrine (NE) release in the cortex (Mountcastle et al., 1972; Aston-Jones and Cohen, 2005). This phasic pattern of activation resembles that found in the DA systems (Schultz et al., 1997). In contrast, tonic baseline activity of the LC corresponds with less efficient task-related behavior in animals (Aston-Jones and Cohen, 2005) and may support exploration in situations where the value of the task at hand has declined (Usher et al., 1999). Projections to the LC from the orbitofrontal cortex (OFC) and anterior cingulate cortex (ACC), areas critical to decision-making (O'Doherty et al., 2003; Hare et al., 2008), may facilitate switching between tonic and phasic modes of operation. MPH increases NE levels in the LC and indeed throughout the brain (Gatley et al., 1996; Kuczenski and Segal, 1997, 2002; Hannestad et al., 2010). MPH reduces both tonic and phasic LC firing in a dose-dependent manner, with more prominent effects at high doses and a stronger effect on phasic than on tonic activity at low doses (Devilbiss and Berridge, 2006).
MPH ameliorates impulsivity both in humans and non-human primates (Rajala et al., 2012, 2015; Berridge and Arnsten, 2013). Thus, examining the effects of MPH on LC connectivity will advance our understanding of its neural mechanisms in impulse control and MPH's therapeutic effects in ADHD (Volkow et al., 1995). Numerous studies revealed an important role of NE in cognition. NA α-1-adrenoceptor antagonist impairs working memory, particularly during induced stress (Birnbaum et al., 1999). NA depletion impaired prefrontal cortical function, which could be restored by NA α-2 agonists (Arnsten et al., 1996). NA dysfunction is implicated in cognitive deficits in Down syndrome (Salehi et al., 2009), schizophrenia, and AD (Friedman et al., 1999). NE also plays a role in affective memory; β-adrenoceptor antagonists impair memory of emotional stimuli (Cahill et al., 1994). NE agents have been widely used in the treatment of depression, with newer medications increasing NE levels along with serotonin and/or dopamine (Nelson et al., 2004; Stahl et al., 2004; Blier and Szabo, 2005; Joffe et al., 2007). Thus, understanding the rsFC of the LC would help advance our knowledge of the cerebral NA system and its relevance to clinical conditions other than ADHD.
Ventral Tegmental Area/Substantia Nigra, Pars Compacta (VTA/SNc)
The VTA/SNc projects to the striatum and neocortex and receives heavy glutamatergic projections from the ventromedial prefrontal cortex (vmPFC), OFC, dorsal ACC (dACC), as well as the hippocampus and amygdala (Haber and Knutson, 2009).
The DA pathway is a major component of the reward system, a network of brain regions that predict and encode value during reward-based processing and learning (Schultz et al., 1997; O'Doherty et al., 2002; McClure et al., 2003; Aron et al., 2005; Haber et al., 2006; D'Ardenne et al., 2008; Haber and Knutson, 2009). Stimulants including MPH, atomoxetine (ATX), and amphetamines influence glutamatergic signaling of DA neurons in the VTA (Kalivas and Weber, 1988; Pert, 1998), with repeated exposure leading to behavioral sensitization to stimulants (Bonci and Williams, 1996; Pierce and Kalivas, 1997), as also observed in humans (Prieto-Gómez et al., 2005; Jones and Dafny, 2013). Psychostimulants may impact the brain via connectivities to the VTA, with dysfunctional changes leading to addiction.
MPH elicited increase in BOLD activity in the SN of rats (Easton et al., 2009). In an arterial spin labeling study of humans, MPH and ATX respectively increased and decreased regional cerebral blood flow to the SN/midbrain (Marquand et al., 2012). MPH also influences VTA/SN activation to behavioral tasks, reversing responses to mental fatigue for both healthy controls and cocaine abusing individuals (Moeller et al., 2012). MPH blocks more than 50% of dopamine transporter and significantly increases levels of extracellular DA in the basal ganglia (Volkow et al., 1995, 1998, 2002). In fMRI, boys with ADHD show increased, while healthy controls show decreased, activity in the striatum under MPH (Vaidya et al., 1998). MPH improves ADHD symptoms by increasing frontal and striato-thalamic activation for inhibitory control (Rubia et al., 2011), but it is unclear whether these effects are mediated by DA projections from VTA (Shen and Choong, 2006; Warton et al., 2009). Examining the influence of MPH on cerebral functional connectivity of VTA/SNc will provide useful information on this issue.
Participants, study procedures, and imaging pre-processing were described in detail in our recent work (Farr et al., 2014a).
Twenty-four healthy adults (16 females; age 25 ± 6 years) participated in the study. All were without medical, neurological, or psychiatric conditions, denied history of head injury and current use of prescription medications or illicit substances, and showed negative urinalysis on the day of fMRI. These 24 participants received a single 45 mg oral dose of MPH before fMRI and comprised the methylphenidate (MPH) group. Data of a cohort of 24 matched healthy participants (16 females; age 24 ± 4 years) scanned under identical imaging protocols except without being given MPH were used for comparison—the no-MPH group. Compared to baseline, MPH increased heart rate, systolic blood pressure, and anxiety rating, as we reported recently (Farr et al., 2014b). All participants provided written consent following a protocol approved by the Yale Human Investigation Committee.
Imaging Protocol and Data Analysis
Conventional T1-weighted spin-echo sagittal anatomical images were acquired for slice localization using a 3T scanner (Siemens Trio). Anatomical images of the functional slice locations were next obtained with spin-echo imaging in the axial plane parallel to the AC-PC line with TR = 300 ms, TE = 2.5 ms, bandwidth = 300 Hz/pixel, flip angle = 60°, field of view = 220 × 220 mm, matrix = 256 × 256, 32 slices with slice thickness = 4 mm and no gap. Functional, BOLD signals were then acquired with a single-shot gradient echo echo-planar imaging (EPI) sequence. Thirty-two axial slices parallel to the AC-PC line covering the whole brain were acquired with repetition time = 2000 ms, echo time = 25 ms, bandwidth = 2004 Hz/pixel, flip angle = 85°, field of view = 220 × 220 mm, matrix = 64 × 64, 32 slices with slice thickness = 4 mm and no gap. Three hundred images were acquired in the resting state during which participants were instructed to close their eyes but stay awake for a period of 10 min (Farr et al., 2014b).
Imaging Data Pre-Processing
Brain imaging data were pre-processed using the same routine as described in our previous work (Zhang et al., 2012). Briefly, images of each individual subject were first realigned (motion corrected) and corrected for slice timing. A mean functional image volume was constructed for each subject from the realigned image volumes. The high-resolution structural image was co-registered with these mean images and then segmented for normalization with affine registration followed by nonlinear transformation (Friston et al., 1995; Ashburner and Friston, 1999). The normalization parameters determined for the structural volume were then applied to the corresponding functional image volumes for each subject. Finally, the images were smoothed with a Gaussian kernel of 8 mm at full width at half maximum.
Additional pre-processing was applied to reduce spurious BOLD variances that were unlikely to reflect neuronal activity (Rombouts et al., 2003; Fox et al., 2006a; Fair et al., 2007; Fox and Raichle, 2007). The sources of spurious variance were removed through linear regression by including the signal from the ventricular system, the white matter and the whole brain, in addition to the six parameters obtained by rigid body head motion correction. First-order derivatives of the whole brain, ventricular, and white matter signals were also included in the regression. Following earlier studies (Cordes et al., 2001; Fox and Raichle, 2007), we applied a temporal band-pass filter (0.009 Hz < f < 0.08 Hz) to the time course in order to obtain low-frequency fluctuations (Fox et al., 2006b; Fair et al., 2007; Fox and Raichle, 2007).
As extensively investigated by Van Dijk et al. (2012), we applied a “scrubbing” method proposed by Power and colleagues (Smyser et al., 2010; Power et al., 2012; Tomasi and Volkow, 2014) to remove time points affected by head motions: for every time point t, we computed the framewise displacement given by FD (t) = |Δdx (t)| + |Δdy (t)| + |Δdz (t)| + r|α (t)| + r|β (t)| + r|γ (t)|, where (dx, dy, dz) and (α, β, γ) are the translational and rotational movements, respectively, and the root mean square variance (DVARS) of the differences in % BOLD intensity I(t) between consecutive time points across brain voxels: . To compute each subject's correlation map, we removed every time point that exceeded the head motion limit FD(t) > 0.5 mm or DVARS(t) > 0.5% (Power et al., 2012; Tomasi and Volkow, 2014). On average, 1% of the time points were removed across subjects.
Figure 1. Seed regions: LC, locus coeruleus; VTA/SNc, ventral tegmental area, pars compacta; BNM, basal nucleus of meynert; VS, ventral striatum (shown for contrast with the BNM; not examined in the current work).
Basal nucleus of Meynert (BNM)
A mask of the BNM was created based on a stereotaxic probabilistic map of magnocellular cell groups in the basal forebrain (Zaborszky et al., 2008), as detailed in our earlier work (Li et al., 2014). Briefly, a T1-weighted MRI scan of 1.17 × 1 × 1 mm was obtained of each individual brain (n = 10) before histological processing. The outlines of various basal forebrain compartments were traced on 2D images of silver-stained (Merker, 1983) histological sections (20 μm thick, 1.2 mm apart) with a resolution of 7000 × 6000 pixels. The outlines were processed as contour line for each histological section. As described in Zaborszky et al. (2008), we used a modified version of the Ch1–Ch4 nomenclature of Mesulam et al. (1983) to delineate the magnocellular basal forebrain cell groups. Cell aggregates in the subcommissural–sublenticular region largely correspond to the BNM as defined by Mesulam et al. (1983); Vogels et al. (1990); De Lacalle et al. (1991); Zaborszky et al. (2008).
Locus coeruleus (LC) and ventral tegmental area/substantia nigra, pars compacta (VTA/SNc)
We used a probabilistic template of the LC derived by Keren et al. (2009). The LC seed region represents the extent of peak LC signal distribution, obtained from a sample of 44 healthy adults (age range: 19–79 years) using high-resolution T1-weighted Turbo Spin Echo (T1-TSE) MRI, and has a volume of 93 mm3. The T1-TSE LC signals were likely influenced by the ferrous neuromelanin metabolites within LC neurons (Sasaki et al., 2006) and observed in sections corresponding to the greatest concentrations of LC cells in postmortem studies (German et al., 1988). The VTA/SNc region was derived from the structural MRIs of 30 healthy adults; after spatial normalization and averaging across subjects, the size of the bilateral mask was 1106 mm3 (Ahsan et al., 2007).
Seed-based Functional Connectivity: Linear Correlations
The BOLD time courses were averaged spatially across all voxels each for the three seed regions. We computed the correlation coefficient between the averaged time course of each mask and the time courses of individual voxels of the brain for individual subjects. To assess and compare the resting state “correlograms,” we converted these image maps, which were not normally distributed, to z score maps by Fisher's z transform (Jenkins and Watts, 1968; Berry and Mielke Jr, 2000): z = 0.5 loge[(1+r)/(1−r)]. The z maps were used in group random effect analyses (Penny et al., 2004) with a two- sample t-test to compare MPH and no-MPH groups. All imaging findings were examined with a peak voxel p < 0.001, uncorrected, combined with a cluster threshold p < 0.05, corrected for family-wise error of multiple comparisons.
Figure 2. (A) Brain regions that show different connectivities between MPH and noMPH groups; (B) Effect size (z-value) of rsFC of brain regions that show different connectivities between MPH and noMPH groups. Values are mean ± standard error; BNM, basal nucleus of Meynert; LC, locus coeruleus; VTA/SNc, ventral tegmental area/substantia nigra pars compacta; PrG, precentral gyrus; MOG, middle occipital gyrus; HC, hippocampus; MOG, middle occipital gyrus; CB, cerebellum; PUT, putamen.
Basal Nucleus of Meynert
Figure 3. Regions with different functional connectivity to the BNM; Warm colors: MPH > no-MPH; Cool colors: MPH < no-MPH; voxel p < 0.001 uncorrected and cluster p < 0.05, FWE corrected. Color bars represent voxel T-value.
Both groups showed positive connectivity of LC with the bilateral cerebellum, with the MPH group showing significantly less positive connectivity. While the no-MPH group showed no significant connectivity of LC with the right hippocampus, the MPH group showed significant positive connectivity (Figures 2, 4; Table 1).
Figure 4. Regions with different functional connectivity to the LC. Warm colors: MPH > no-MPH; Cool colors: MPH < no-MPH; voxel p < 0.001 uncorrected; and cluster p < 0.05, FWE corrected. Color bars represent voxel T-value.
Ventral Tegmental Area/Substantia Nigra, Pars Compacta (VTA/SNc)
While the no-MPH group showed negative VTA/SNc connectivity with the left middle occipital gyrus (MOG), the MPH group showed no significant connectivity. Both groups showed positive VTA/SNc connectivity with bilateral cerebellum, with the MPH group showing lower connectivity than the no-MPH group. While the no-MPH group showed positive connectivity with bilateral putamen the MPH group showed no significant connectivity (Figures 2, 5; Table 1).
Figure 5. Regions with different functional connectivity to the VTA/SNc. Warm colors: MPH > no-MPH; Cool colors: MPH < no-MPH; voxel p < 0.001 uncorrected; and cluster p < 0.05, FWE corrected. Color bars represent voxel T-value.
Analyses without Global Signal Regression in Data Pre-Processing
We re-analyzed the data without using global signal regression in pre-processing. The findings showed that changes in functional connectivity were slightly diminished in significance but were otherwise similar. To confirm the findings, we extracted the effect size of connectivity (in data without global signal regression) of the ROIs as identified from the original analysis for comparison between the MPH and no-MPH groups (Figure 2). The results showed that the effect size of connectivity difference remained highly significant: BNM—L Precentral Gyrus (p < 0.00001); BNM—R Precentral Gyrus (p < 0.00002); LC—Cerebellum (p < 0.000001); LC—Hippocampus (p < 0.0004); VTA/SNc—Cerebellum (p < 0.000001); VTA/SNc—Putamen (p < 0.0012); and VTA/SNc—Left MOG (p < 0.0010).
Basal Nucleus of Meynert
Anatomically, VTA/SNc projects directly to the BNM (Gaykema and Zaborszky, 1996). The dopamine-beta-hydroxylase and tyrosine-hydroxylase containing axons meet the cholinergic neurons, suggesting catecholaminergic modulation of cholinergic activity (Zaborsky and Cullinan, 1996). BNM provides cholinergic inputs to most of the cerebral cortex, including the primary motor cortex (PMC; Pearson et al., 1983) and receives projections from the OFC and VS (Mesulam and Mufson, 1984), both of which are targets of DA projections and implicated in reward prediction, valuation, and decision-making (Haber et al., 2006; Haber and Knutson, 2009). Thus, MPH-induced increases in functional connectivity between BNM and motor cortex may be mediated directly by VTA/SNc DA projections or indirectly via the OFC and VS.
MPH's effects on the motor systems are well-documented. MPH increased frontal activation in both healthy and ADHD children (Vaidya et al., 1998). MPH increased the intensity and decreased inhibition of motor responses in studies of transcranial magnetic stimulation in both healthy individuals (Ilic et al., 2003) and ADHD patients (Gilbert et al., 2005). MPH also increased activity in lateral premotor areas in a four-choice reaction time task (Müller et al., 2005). Additionally, basal forebrain cholinergic outputs are required for motor learning. Lesions of the rodent homolog of BNM depleted cholinergic innervation to the cortex by more than 99% and led to slower and less accurate responses in motor learning, but not in performing a previously learned motor task (Conner et al., 2003, 2005, 2010). Together, BNM and its cholinergic outputs to the motor cortex are essential for motor control and learning, and MPH may influence this process by reversing the negative BNM—motor cortical connectivity.
MPH elicited reversal of the sign of BNM—motor cortical connectivity may have treatment implications for PD. Combined with levodopa (L-Dopa), MPH improves hand tapping speed but worsens dyskinesia symptoms as compared to L-Dopa alone (Camicioli et al., 2001). MPH alone improved reaction time in a choice task (Camicioli et al., 2001) but may improve (Devos et al., 2007; Moreau et al., 2012) or worsen (Espay et al., 2011) gait symptoms in PD patients. These complexities need to be resolved in the future.
MPH significantly reduced positive LC connectivity with specific regions of the cerebellar cortex, likely lobules IV, V, and X (Schmahmann et al., 2000). LC is the primary source of NA projections to the cerebellum and cerebral cortex (Berridge and Waterhouse, 2003). LC projects to the cerebellum via the superior cerebellar peduncle (Moore and Bloom, 1979) and synapses with inhibitory Purkinje cell dendrites in the Purkinje and molecular layers (Ito et al., 1964; Hoffer et al., 1973; Moises and Woodward, 1980). Thus, MPH may alter activities of inhibitory Purkinje cells in the cerebellum. Given that areas of the cerebellum are specialized for fine-tuning of motor control and/or calibration of motor output (Middleton and Strick, 2000), it is possible that MPH's effect on the reduction of positive connectivity represents a shift away from fine in favor of gross motor function.
It has been suggested that long-term potentiation (LTP) in the hippocampus is mediated by NA activity (Ramos and Arnsten, 2007). Increases in NE, as elicited by an alpha-1-adrenergic agonist, significantly increased LTP in the hippocampus (Izumi and Zorumski, 1999). MPH increases NE levels (Weikop et al., 2007) and enhances both LTP and long-term depression in the hippocampus, both of which were blocked by a beta-noradrenoceptor antagonist (Dommett et al., 2008). Thus, MPH-evoked increases in LC connectivity to the hippocampus may alter learning and memory.
Indeed, MPH improved 1-week retention of both casually and intentionally learned information when administered 12 h after learning (Izquierdo et al., 2008). When administered before testing, MPH improved word recall, but not spatial working memory in healthy adults (Verster et al., 2010; Linssen et al., 2012). In contrast, MPH appears to reduce emotional memory despite producing increased arousal for emotional stimuli (Brignell et al., 2007). Polymorphisms of Catechol-O-methyltransferase (COMT) gene have been associated with different degrees of cognitive improvements under amphetamine (Mattay et al., 2003), highlighting inter-subject variation in the effects of psychostimulants on cognitive functions.
Ventral Tegmental Area/Substantia Nigra, Pars Compacta (VTA/SNc)
Thus, MPH diminishes negative connectivity between VTA/SNc and left MOG. While the prefrontal cortex receives both direct NE and DA projections, the occipital cortex receives scarce DA projections in the rat (Descarries et al., 1987; Lidow et al., 1991; Devoto et al., 2001). On the other hand, extra-cellular DA in the rat occipital cortex is only 37% lower than that in the mPFC (Devoto et al., 2003). In this same study, when an NE antagonist was injected into LC, NE, and DA levels in the occipital cortex fell 50 and 70%, respectively (Devoto et al., 2003). Conversely, a NE-agonist increased both occipital NE and DA (Devoto et al., 2004). Combined, these results suggest that occipital cortical DA may originate from co-release of DA and NE from LC neurons (Devoto et al., 2003, 2004).
It is plausible that MPH diminishes negative connectivity between VTA/SNc and the MOG as a result of complex interaction of NA and DA systems. Further, DA projections to cortex are more abundant in primates including humans than in rats (Björklund and Dunnett, 2007); for example, varying levels of DA-receptor mRNA have been found in the human occipital cortex, with D1 and D3 receptor transcripts being the most and least prominent, respectively (Meador-Woodruff et al., 1996). Further research should clarify this interaction and investigate its effect on behavior.
Many studies have implicated the MOG in ADHD. In diffusion tensor imaging (DTI), ADHD patients show reductions in trace (a measure of diffusion magnitude) in the left MOG (Alexander et al., 2007; Chaim et al., 2014). More specifically, children with ADHD inattentive subtype exhibit increased radial diffusivity (diffusion perpendicular to fiber direction) compared to healthy controls (Lei et al., 2014). Lower fractional anisotropy in the fronto-occipital fasciculus is correlated with greater inattention symptoms in ADHD adults (Shaw et al., 2014). Functional differences in the MOG are also associated with ADHD. Visual regions including the MOG show decreased nodal efficiency during a working memory task in ADHD based on a “small-world” regime (Xia et al., 2014). In activation likelihood estimation meta-analysis, the MOG is less likely to be active in ADHD patients during executive function compared to controls (Dickstein et al., 2006). Thus, one is tempted to speculate that the treatment effects of MPH in ADHD may at least in part be related to functional connectivity between the MOG and VTA/SNc.
MPH reduced positive connectivity between VTA/SNc and multiple areas of the dorsomedial cerebellum including the vermis, culmen, and medial hemispheres. The cerebellum is important to cognition and motor control, with distinct areal connections to motor and prefrontal cortices (Middleton and Strick, 2000). The medial cerebellar cortex and dorsal cerebellar nuclei are more involved in motor coordination than lateral cerebellar hemispheres and ventrolateral cerebellar nuclei, which are more involved in learning and cognition (Jueptner et al., 1997a,b). Thus, the reduction in VTA/SNc positive connectivity to the vermis, culmen, and medial cerebellum may suggest a damping effect of MPH on motor activity.
Acute stimulation of the VTA/SNc increases cFOS immunoreactivity, an indirect measure of brain activity, in the dorsal cerebellum, and chronic DA antagonism decreased cFOS in the dorsal vermis while increasing it in the dorsal cerebellar hemisphere (Herrera-Meza et al., 2014). Administration of dextroamphetamine, a competitive DA agonist, increases activity in the dorsomedial cerebellum (Ernst et al., 1997; Schouw et al., 2013). While studies have shown a relative lack of DA in the cerebellum compared to the basal ganglia (Wagner et al., 1983; Martres et al., 1985; Jucaite et al., 2006), other work has uncovered anatomical connections between VTA and cerebellum (Ikai et al., 1992) as well as tyrosine hydroxylase- and dopamine transporter-immunoreactive axons (Melchitzky and Lewis, 2000), DA D5 receptors (Khan et al., 2000), and DA neurons (Hurley et al., 2003), supporting potential actions of the MPH in the cerebellum.
Cerebellum has been implicated in catecholaminergic dysfunction. Mice generated with decreased levels of monoamine oxidase A (MAO-A), an enzyme integral to maintaining normal catecholamine levels, exhibit smaller cerebellums, decreased Purkinje cell count and dendritic density, and vermal hypoplasia (Alzghoul et al., 2012). MAO-A/B knockout mice also show enhanced eye-blink conditioning, which depends on cerebellar integrity, suggesting another critical cerebellar process contingent on catecholaminergic signaling (Singh et al., 2013).
The link between catecholaminergic function and the cerebellum may lead to new insights in treating motor disorders like PD. DA signaling from the striatum, as well as input from the cerebellum, influences the plasticity of the PMC during motor learning, a process known to be abnormal in PD (Kishore et al., 2014). Also, a model for the dyskinesia symptoms caused by levodopa, a common treatment for PD, implicates dysfunctions in cerebellar modulation of sensory projections to the PMC (Kishore et al., 2014; Kishore and Popa, 2014). In the latter hypothesis DA regulation is critical to proper cerebellar and motor function as a whole, and supports the influence of MPH on cerebellar connectivity.
MPH increases cerebellar activity in both ADHD adults and children (Epstein et al., 2007), and restores cerebellar response during successful response inhibition (Rubia et al., 2011). A T2 relaxometry study, which uses T2 relaxation time to estimate cerebral blood flow, also suggests a normalizing effect of MPH on cerebellar activity in ADHD, with hyperactive and non-hyperactive subjects, respectively, exhibiting an increase and decrease in T2 relaxation time under MPH (Anderson et al., 2002). In a non-ADHD population, MPH significantly increases metabolic activity in the cerebellum of cocaine addicts, and D2 receptor availabilities are significantly correlated with the increase in metabolism (Volkow et al., 1999). These results again support our finding of significant interaction between MPH and VTA/SNc-cerebellum connectivity. With the link of the cerebellum to execution of learned motor tasks (Jueptner et al., 1997a), as well as memory (Imamizu et al., 2000) and recall (Shadmehr and Holcomb, 1997) of motor skills, MPH's effect may underlie reductions in hyperactivity in ADHD (Cohen et al., 1971), and/or represent a more global shift to support cognitive over motor functions.
Limitations and Conclusions
Several issues should be considered. First, this observational study is based on a between-subjects design and did not involve a placebo control; thus, the placebo effect may confound the results. Further, we did not control for individual differences such as personality traits and pharmacokinetics, which may underlie variability of the effects of MPH. Thus, although the MPH and no-MPH groups are also individually matched in age and gender, the current results should be considered as preliminary and require replication in future work with a within-subject design. Second, the LC seed is very small. Although our recent study examined and negated the influence of physiological signals on BOLD activity and functional connectivity of the LC (Zhang et al., 2015), more studies with higher field magnet are needed to provide the spatial resolution needed to confirm the current findings. Third, we did not include any assessment of cognitive or motor performance, so the functional implications of our findings need to be reconsidered in follow-up work.
In summary, MPH had varying effects on the functional connectivity of BNM, LC, and VTA/SN. MPH reversed negative BNM connectivity with bilateral precentral gyrus, in accord with its effects on motor control and learning in ADHD and PD. MPH decreased positive connectivity between LC and cerebellum, which may underlie priming for cognitive over motor processing. MPH increased connectivity between LC and hippocampus, a change that may underlie reported improvements in memory. MPH eliminated or nearly eliminated connectivity of VTA/SNc with the cerebellum, putamen and left MOG, suggesting a DA mechanism of its effects on cognitive motor processing and visual attention. However, the current findings are obtained in healthy individuals and may not readily generalize to neuropsychiatric populations.
All authors made substantial contributions to the conception or design of the work, data acquisition and analysis, interpretation of data; and drafting or revising the work for publication. All authors approved the final version and agreed to be accountable for the whole contents of the work.
This study is supported by NIH grants DA026990, DA023248, AA021449, NS23945 (LZ), T32 NS07224 (OMF), and K25DA040032 (SZ) as well as the Peter McManus Trust, and conducted partly as a senior thesis project (RK) in the Department of Psychology at Yale University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Drug Abuse or the National Institutes of Health.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Advokat, C. (2010). What are the cognitive effects of stimulant medications? emphasis on adults with attention-deficit/hyperactivity disorder (ADHD). Neurosci. Biobehav. Rev. 34, 1256–1266. doi: 10.1016/j.neubiorev.2010.03.006
Ahsan, R. L., Allom, R., Gousias, I. S., Habib, H., Turkheimer, F. E., Free, S., et al. (2007). Volumes, spatial extents and a probabilistic atlas of the human basal ganglia and thalamus. Neuroimage 38, 261–270. doi: 10.1016/j.neuroimage.2007.06.004
Alzghoul, L., Bortolato, M., Delis, F., Thanos, P. K., Darling, R. D., Godar, S. C., et al. (2012). Altered cerebellar organization and function in monoamine oxidase A hypomorphic mice. Neuropharmacology 63, 1208–1217. doi: 10.1016/j.neuropharm.2012.08.003
Anderson, C. M., Polcari, A., Lowen, S. B., Renshaw, P. F., and Teicher, M. H. (2002). Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in boys with ADHD. Am. J. Psychiatry 159, 1322–1328. doi: 10.1176/appi.ajp.159.8.1322
Arnsten, A. F., Steere, J. C., and Hunt, R. D. (1996). The contribution of α2-noradrenergic mechanisms to prefrontal cortical cognitive function: potential significance for attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry 53, 448–455. doi: 10.1001/archpsyc.1996.01830050084013
Aron, A., Fisher, H., Mashek, D. J., Strong, G., Li, H., and Brown, L. L. (2005). Reward, motivation, and emotion systems associated with early-stage intense romantic love. J. Neurophysiol. 94, 327–337. doi: 10.1152/jn.00838.2004
Aston-Jones, G., and Cohen, J. D. (2005). An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu. Rev. Neurosci. 28, 403–450. doi: 10.1146/annurev.neuro.28.061604.135709
Aston-Jones, G., Foote, S., and Segal, M. (1985). Impulse conduction properties of noradrenergic locus coeruleus axons projecting to monkey cerebrocortex. Neuroscience 15, 765–777. doi: 10.1016/0306-4522(85)90077-6
Berridge, C. W., and Waterhouse, B. D. (2003). The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Rev. 42, 33–84. doi: 10.1016/S0165-0173(03)00143-7
Berry, K. J., and Mielke Jr, P. W. (2000). A monte carlo investigation of the fisher Z transformation for normal and nonnormal distributions. Psychol. Rep. 87, 1101–1114. doi: 10.2466/PR0.87.7.1101-1114
Birnbaum, S., Gobeske, K., Auerbach, J., Taylor, J., and Arnsten, A. (1999). A role for norepinephrine in stress-induced cognitive deficits: α-1-adrenoceptor mediation in the prefrontal cortex. Biol. Psychiatry 46, 1266–1274. doi: 10.1016/s0006-3223(99)00138-9
Bodick, N. C., Offen, W. W., Levey, A. I., Cutler, N. R., Gauthier, S. G., Satlin, A., et al. (1997). Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in alzheimer disease. Arch. Neurol. 54, 465–473. doi: 10.1001/archneur.1997.00550160091022
Bonci, A., and Williams, J. T. (1996). A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16, 631–639. doi: 10.1016/S0896-6273(00)80082-3
Brignell, C. M., Rosenthal, J., and Curran, H. V. (2007). Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam. J. Psychopharmacol. 21, 673–683. doi: 10.1177/0269881107077351
Camicioli, R., Lea, E., Nutt, J. G., Sexton, G., and Oken, B. S. (2001). Methylphenidate increases the motor effects of L-dopa in parkinson's disease: a pilot study. Clin. Neuropharmacol. 24, 208–213. doi: 10.1097/00002826-200107000-00003
Candy, J., Perry, R., Perry, E., Irving, D., Blessed, G., Fairbairn, A., et al. (1983). Pathological changes in the nucleus of meynert in alzheimer's and parkinson's diseases. J. Neurol. Sci. 59, 277–289. doi: 10.1016/0022-510X(83)90045-X
Chaim, T. M., Zhang, T., Zanetti, M. V., da Silva, M. A., Louzã, M. R., Doshi, J., et al. (2014). Multimodal magnetic resonance imaging study of treatment-naïve adults with attention-deficit/hyperactivity disorder. PLoS ONE 9:e110199. doi: 10.1371/journal.pone.0110199
Cohen, N. J., Douglas, V. I., and Morgenstern, G. (1971). The effect of methylphenidate on attentive behavior and autonomic activity in hyperactive children. Psychopharmacologia 22, 282–294. doi: 10.1007/BF00401790
Conner, J. M., Chiba, A. A., and Tuszynski, M. H. (2005). The basal forebrain cholinergic system is essential for cortical plasticity and functional recovery following brain injury. Neuron 46, 173–179. doi: 10.1016/j.neuron.2005.03.003
Conner, J. M., Culberson, A., Packowski, C., Chiba, A. A., and Tuszynski, M. H. (2003). Lesions of the basal forebrain cholinergic system impair task acquisition and abolish cortical plasticity associated with motor skill learning. Neuron 38, 819–829. doi: 10.1016/S0896-6273(03)00288-5
Conner, J. M., Kulczycki, M., and Tuszynski, M. H. (2010). Unique contributions of distinct cholinergic projections to motor cortical plasticity and learning. Cereb. Cortex 20, 2739–2748. doi: 10.1093/cercor/bhq022
Cordes, D., Haughton, V. M., Arfanakis, K., Carew, J. D., Turski, P. A., Moritz, C. H., et al. (2001). Frequencies contributing to functional connectivity in the cerebral cortex in “resting-state” data. Am. J. Neuroradiol. 22, 1326–1333.
Cordes, D., Haughton, V. M., Arfanakis, K., Wendt, G. J., Turski, P. A., Moritz, C. H., et al. (2000). Mapping functionally related regions of brain with functional connectivity MR imaging. Am. J. Neuroradiol. 21, 1636–1644.
D'Ardenne, K., McClure, S. M., Nystrom, L. E., and Cohen, J. D. (2008). BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science 319, 1264–1267. doi: 10.1126/science.1150605
De Lacalle, S., Iraizoz, J., and Ma Gonzalo, L. (1991). Differential changes in cell size and number in topographic subdivisions of human basal nucleus in normal aging. Neuroscience 43, 445–456. doi: 10.1016/0306-4522(91)90307-A
Descarries, L., Lemay, B., Doucet, G., and Berger, B. (1987). Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neuroscience 21, 807–824. doi: 10.1016/0306-4522(87)90038-8
Devos, D., Krystkowiak, P., Clement, F., Dujardin, K., Cottencin, O., Waucquier, N., et al. (2007). Improvement of gait by chronic, high doses of methylphenidate in patients with advanced parkinson's disease. J. Neurol. Neurosurg. Psychiatry 78, 470–475. doi: 10.1136/jnnp.2006.100016
Devoto, P., Flore, G., Longu, G., Pira, L., and Gessa, G. L. (2003). Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex. Synapse 50, 200–205. doi: 10.1002/syn.10264
Devoto, P., Flore, G., Pani, L., and Gessa, G. L. (2001). Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol. Psychiatry 6, 657–664. doi: 10.1038/sj.mp.4000904
Devoto, P., Flore, G., Pira, L., Longu, G., and Gessa, G. L. (2004). Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex. J. Neurochem. 88, 1003–1009. doi: 10.1046/j.1471-4159.2003.02239.x
Dickstein, S. G., Bannon, K., Castellanos, X. F., and Milham, M. P. (2006). The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J. Child Psychol. Psychiatry 47, 1051–1062. doi: 10.1111/j.1469-7610.2006.01671.x
Dommett, E. J., Henderson, E. L., Westwell, M. S., and Greenfield, S. A. (2008). Methylphenidate amplifies long-term plasticity in the hippocampus via noradrenergic mechanisms. Learn. Mem. 15, 580–586. doi: 10.1101/lm.1092608
Easton, N., Marshall, F. H., Marsden, C. A., and Fone, K. C. (2009). Mapping the central effects of methylphenidate in the rat using pharmacological MRI BOLD contrast. Neuropharmacology, 57:653–664. doi: 10.1016/j.neuropharm.2009.08.018
Epstein, J. N., Casey, B., Tonev, S. T., Davidson, M. C., Reiss, A. L., Garrett, A., et al. (2007). ADHD-and medication-related brain activation effects in concordantly affected parent–child dyads with ADHD. J. Child Psychol. Psychiatry 48, 899–913. doi: 10.1111/j.1469-7610.2007.01761.x
Ernst, M., Zametkin, A. J., Matochik, J., Schmidt, M., Jons, P. H., Liebenauer, L. L., et al. (1997). Intravenous dextroamphetamine and brain glucose metabolism. Neuropsychopharmacology 17, 391–401. doi: 10.1016/S0893-133X(97)00088-2
Espay, A. J., Dwivedi, A. K., Payne, M., Gaines, L., Vaughan, J. E., Maddux, B. N., et al. (2011). Methylphenidate for gait impairment in parkinson disease: A randomized clinical trial. Neurology 76, 1256–1262. doi: 10.1212/WNL.0b013e3182143537
Fair, D. A., Schlaggar, B. L., Cohen, A. L., Miezin, F. M., Dosenbach, N. U., Wenger, K. K., et al. (2007). A method for using blocked and event-related fMRI data to study “resting state” functional connectivity. Neuroimage 35, 396–405. doi: 10.1016/j.neuroimage.2006.11.051
Farr, O. M., Hu, S., Matuskey, D., Zhang, S., Abdelghany, O., and Li, C. S. R. (2014b). The effects of methylphenidate on cerebral activations to salient stimuli in healthy adults. Exp. Clin. Psychopharmacol. 22, 154–165. doi: 10.1037/a0034465
Farr, O. M., Zhang, S., Hu, S., Matuskey, D., Abdelghany, O., Malison, R. T., et al. (2014a). The effects of methylphenidate on resting-state striatal, thalamic and global functional connectivity in healthy adults. Int. J. Neuropsychopharmacol. 17, 1177–1191. doi: 10.1017/S1461145714000674
Fox, M. D., Corbetta, M., Snyder, A. Z., Vincent, J. L., and Raichle, M. E. (2006b). Spontaneous neuronal activity distinguishes human dorsal and ventral attention systems. Proc. Natl. Acad. Sci. U.S.A. 103, 10046–10051. doi: 10.1073/pnas.0604187103
Fox, M. D., Snyder, A. Z., Zacks, J. M., and Raichle, M. E. (2006a). Coherent spontaneous activity accounts for trial-to-trial variability in human evoked brain responses. Nat. Neurosci. 9, 23–25. doi: 10.1038/nn1616
Friedman, J. I., Adler, D. N., and Davis, K. L. (1999). The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and alzheimer's disease. Biol. Psychiatry 46, 1243–1252. doi: 10.1016/S0006-3223(99)00232-2
Gatley, S. J., Pan, D., Chen, R., Chaturvedi, G., and Ding, Y. (1996). Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci. 58, PL231–PL239. doi: 10.1016/0024-3205(96)00052-5
Gaykema, R., and Zaborszky, L. (1996). Direct catecholaminergic-cholinergic interactions in the basal forebrain. II. substantia nigra-ventral tegmental area projections to cholinergic neurons. J. Comp. Neurol. 374, 555–577.
German, D. C., Walker, B. S., Manaye, K., Smith, W. K., Woodward, D. J., and North, A. J. (1988). The human locus coeruleus: computer reconstruction of cellular distribution. J. Neurosci. 8, 1776–1788.
Gilbert, D. L., Ridel, K. R., Sallee, F. R., Zhang, J., Lipps, T. D., and Wassermann, E. M. (2005). Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. Neuropsychopharmacology 31, 442–449. doi: 10.1038/sj.npp.1300806
Haber, S. N., Kim, K. S., Mailly, P., and Calzavara, R. (2006). Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning. J. Neurosci. 26, 8368–8376. doi: 10.1523/JNEUROSCI.0271-06.2006
Hannestad, J., Gallezot, J., Planeta-Wilson, B., Lin, S., Williams, W. A., van Dyck, C. H., et al. (2010). Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo. Biol. Psychiatry 68, 854–860. doi: 10.1016/j.biopsych.2010.06.017
Hare, T. A., O'Doherty, J., Camerer, C. F., Schultz, W., and Rangel, A. (2008). Dissociating the role of the orbitofrontal cortex and the striatum in the computation of goal values and prediction errors. J. Neurosci. 28, 5623–5630. doi: 10.1523/JNEUROSCI.1309-08.2008
Herrera-Meza, G., Aguirre-Manzo, L., Coria-Avila, G., Lopez-Meraz, M., Toledo-Cárdenas, R., Manzo, J., et al. (2014). Beyond the basal ganglia: CFOS expression in the cerebellum in response to acute and chronic dopaminergic alterations. Neuroscience 267, 219–231. doi: 10.1016/j.neuroscience.2014.02.046
Hoffer, B. J., Siggins, G. R., Oliver, A. P., and Bloom, F. E. (1973). Activation of the pathway from locus coeruleus to rat cerebellar purkinje neurons: pharmacological evidence of noradrenergic central inhibition. J. Pharmacol. Exp. Ther. 184, 553–569.
Hurley, M. J., Mash, D. C., and Jenner, P. (2003). Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR. Eur. J. Neuroscience 18, 2668–2672. doi: 10.1046/j.1460-9568.2003.02963.x
Ikai, Y., Takada, M., Shinonaga, Y., and Mizuno, N. (1992). Dopaminergic and non-dopaminergic neurons in the ventral tegmental area of the rat project, respectively, to the cerebellar cortex and deep cerebellar nuclei. Neuroscience 51, 719–728. doi: 10.1016/0306-4522(92)90310-X
Izquierdo, I., Bevilaqua, L. R., Rossato, J. I., Lima, R. H., Medina, J. H., and Cammarota, M. (2008). Age-dependent and age-independent human memory persistence is enhanced by delayed posttraining methylphenidate administration. Proc. Natl. Acad. Sci. U.S.A. 105, 19504–19507. doi: 10.1073/pnas.0810650105
Janowsky, D. S., Davis, J. M., El-Yousef, M. K., and Sekerke, H. J. (1973). Antagonistic effects of physostigmine and methylphenidate in man. Am. J. Psychiatry 130, 1370–1376. doi: 10.1176/ajp.130.12.1370
Joffe, H., Soares, C. N., Petrillo, L. F., Viguera, A. C., Somley, B. L., Koch, J. K., et al. (2007). Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. J. Clin. Psychiatry 68, 943–950. doi: 10.4088/JCP.v68n0619
Jones, Z., and Dafny, N. (2013). Acute and chronic dose–response effect of methylphenidate on ventral tegmental area neurons correlated with animal behavior. J. Neural Transm. 121, 327–345. doi: 10.1007/s00702-013-1101-2
Jucaite, A., Odano, I., Olsson, H., Pauli, S., Halldin, C., and Farde, L. (2006). Quantitative analyses of regional [11C] PE2I binding to the dopamine transporter in the human brain: a PET study. Eur. J. Nucl. Med. Mol. Imaging 33, 657–668. doi: 10.1007/s00259-005-0027-9
Jueptner, M., Frith, C. D., Brooks, D. J., Frackowiak, R. S., and Passingham, R. E. (1997a). Anatomy of motor learning. II. subcortical structures and learning by trial and error. J. Neurophysiol. 77, 1325–1337.
Jueptner, M., Stephan, K. M., Frith, C. D., Brooks, D. J., Frackowiak, R. S., and Passingham, R. E. (1997b). Anatomy of motor learning. I. frontal cortex and attention to action. J. Neurophysiol. 77, 1313–1324.
Khan, Z. U., Gutierrez, A., Martın, R., Penafiel, A., Rivera, A., and De La Calle, A. (2000). Dopamine D5 receptors of rat and human brain. Neuroscience 100, 689–699. doi: 10.1016/S0306-4522(00)00274-8
Khromova, I., Rauhala, P., Zolotov, N., and Mannisto, P. T. (1995). Tolcapone, an inhibitor of catechol O-methyltransferase, counteracts memory deficits caused by bilateral cholinotoxin lesions of the basal nuclei of Meynert. Neuroreport 6, 1219–1222. doi: 10.1097/00001756-199505300-00036
Kuczenski, R., and Segal, D. S. (1997). Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 68, 2032–2037. doi: 10.1046/j.1471-4159.1997.68052032.x
Kuczenski, R., and Segal, D. S. (2002). Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J. Neurosci. 22, 7264–7271.
Lange, K. W., Reichl, S., Lange, K. M., Tucha, L., and Tucha, O. (2010). The history of attention deficit hyperactivity disorder. ADHD Atten. Defic. Hyperact. Disord. 2, 241–255. doi: 10.1007/s12402-010-0045-8
Lei, D., Ma, J., Du, X., Shen, G., Jin, X., and Gong, Q. (2014). Microstructural abnormalities in the combined and inattentive subtypes of attention deficit hyperactivity disorder: a diffusion tensor imaging study. Scientific Rep. 4:6875. doi: 10.1038/srep06875
Li, C.-S., Ide, J. S., Zhang, S., Hu, S., Chao, H. H., and Zaborszky, L. (2014). Resting state functional connectivity of the basal nucleus of Meynert in humans: in comparison to the ventral striatum and the effects of age. Neuroimage 97, 321–332. doi: 10.1016/j.neuroimage.2014.04.019
Lidow, M. S., Goldman-Rakic, P. S., Gallager, D. W., and Rakic, P. (1991). Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3 H] raclopride,[3 H] spiperone and [3 H] SCH23390. Neuroscience 40, 657–671. doi: 10.1016/0306-4522(91)90003-7
Linssen, A., Vuurman, E., Sambeth, A., and Riedel, W. (2012). Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteers. Psychopharmacology 221, 611–619. doi: 10.1007/s00213-011-2605-9
Manza, P., Zhang, S., Hu, S., Chao, H. H., Leung, H. C., and Chiang-shan, R. L. (2015). The effects of age on resting state functional connectivity of the basal ganglia from young to middle adulthood. Neuroimage 107, 311–322. doi: 10.1016/j.neuroimage.2014.12.016
Marquand, A. F., O'Daly, O. G., De Simoni, S., Alsop, D. C., Maguire, R. P., Williams, S. C., et al. (2012). Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach. Neuroimage 60, 1015–1024. doi: 10.1016/j.neuroimage.2012.01.058
Martres, M. P., Bouthenet, M. L., Sales, N., Sokoloff, P., and Schwartz, J. C. (1985). Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand. Science 228, 752–755.
Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., et al. (2003). Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc. Natl. Acad. Sci. U.S.A. 100, 6186–6191. doi: 10.1073/pnas.0931309100
Meador-Woodruff, J. H., Damask, S. P., Wang, J., Haroutunian, V., Davis, K. L., and Watson, S. J. (1996). Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 15, 17–29. doi: 10.1016/0893-133X(95)00150-C
Melchitzky, D. S., and Lewis, D. A. (2000). Tyrosine hydroxylase-and dopamine transporter-immunoreactive axons in the primate cerebellum. Neuropsychopharmacology 22, 466–472. doi: 10.1016/S0893-133X(99)00139-6
Mesulam, M. M., and Mufson, E. J. (1984). Neural inputs into the nucleus basalis of the substantia innominata (Ch4) in the rhesus monkey. Brain J. Neurol. 107 (Pt 1), 253–274. doi: 10.1093/brain/107.1.253
Mesulam, M.-M., Mufson, E. J., Levey, A. I., and Wainer, B. H. (1983). Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the Rhesus monkey. J. Comp. Neurol. 214, 170–197. doi: 10.1002/cne.902140206
Moeller, S. J., Tomasi, D., Honorio, J., Volkow, N. D., and Goldstein, R. Z. (2012). Dopaminergic involvement during mental fatigue in health and cocaine addiction. Transl. Psychiatry 2:e176. doi: 10.1038/tp.2012.110
Moore, R., and Bloom, F. (1979). Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Ann. Rev. Neurosci. 2, 113–168. doi: 10.1146/annurev.ne.02.030179.000553
Moreau, C., Delval, A., Defebvre, L., Dujardin, K., Duhamel, A., Petyt, G., et al. (2012). Methylphenidate for gait hypokinesia and freezing in patients with parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol. 11, 589–596. doi: 10.1016/S1474-4422(12)70106-0
Mountcastle, V. B., LaMotte, R. H., and Carli, G. (1972). Detection thresholds for stimuli in humans and monkeys: comparison with threshold events in mechanoreceptive afferent nerve fibers innervating the monkey hand. J. Neurophysiol. 35, 122–136.
Müller, U., Suckling, J., Zelaya, F., Honey, G., Faessel, H., Williams, S., et al. (2005). Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes. Psychopharmacology 180, 624–633. doi: 10.1007/s00213-005-2264-9
Nelson, J. C., Mazure, C. M., Jatlow, P. I., Bowers, M. B. Jr., and Price, L. H. (2004). Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Biol. Psychiatry 55, 296–300. doi: 10.1016/j.biopsych.2003.08.007
O'Doherty, J. P., Dayan, P., Friston, K., Critchley, H., and Dolan, R. J. (2003). Temporal difference models and reward-related learning in the human brain. Neuron 38, 329–337. doi: 10.1016/S0896-6273(03)00169-7
Perry, E. K., Curtis, M., Dick, D. J., Candy, J. M., Atack, J. R., Bloxham, C. A., et al. (1985). Cholinergic correlates of cognitive impairment in parkinson's disease: comparisons with alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 48, 413–421. doi: 10.1136/jnnp.48.5.413
Pierce, R. C., and Kalivas, P. W. (1997). A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Brain Res. Rev. 25, 192–216. doi: 10.1016/S0165-0173(97)00021-0
Power, J. D., Barnes, K. A., Snyder, A. Z., Schlaggar, B. L., and Petersen, S. E. (2012). Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage 59 2142–2154. doi: 10.1016/j.neuroimage.2011.10.018
Prieto-Gómez, B., Vázquez-Alvarez, A. M., Martínez-Peña, J. L., Reyes-Vázquez, C., Yang, P. B., and Dafny, N. (2005). Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area. Life Sci. 77, 635–649. doi: 10.1016/j.lfs.2004.10.076
Rajala, A. Z., Henriques, J. B., and Populin, L. C. (2012). Dissociative effects of methylphenidate in nonhuman primates: trade-offs between cognitive and behavioral performance. J. Cogn. Neurosci. 24, 1371–1381. doi: 10.1162/jocn_a_00225
Rajala, A. Z., Jenison, R. L., and Populin, L. C. (2015). Decision-making: effects of methylphenidate on temporal discounting in non-human primates. J. Neurophysiol. 114, 70–79. doi: 10.1152/jn.00278.2015
Reinikainen, K., Soininen, H., and Riekkinen, P. (1990). Neurotransmitter changes in alzheimer's disease: implications to diagnostics and therapy. J. Neurosci. Res. 27, 576–586. doi: 10.1002/jnr.490270419
Ridley, R., Murray, T., Johnson, J., and Baker, H. (1986). Learning impairment following lesion of the basal nucleus of meynert in the marmoset: modification by cholinergic drugs. Brain Res. 376, 108–116. doi: 10.1016/0006-8993(86)90904-2
Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., and Friedhoff, L. T. (1998). A 24-week, double-blind, placebo-controlled trial of donepezil in patients with alzheimer's disease. Donepezil study group. Neurology 50, 136–145. doi: 10.1212/wnl.50.1.136
Rombouts, S., Stam, C., Kuijer, J., Scheltens, P., and Barkhof, F. (2003). Identifying confounds to increase specificity during a “no task condition”: evidence for hippocampal connectivity using fMRI. Neuroimage 20, 1236–1245. doi: 10.1016/S1053-8119(03)00386-0
Rubia, K., Halari, R., Cubillo, A., Smith, A. B., Mohammad, A., Brammer, M., et al. (2011). Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naive boys with attention-deficit hyperactivity disorder. Neuropsychopharmacology 36, 1575–1586. doi: 10.1038/npp.2011.30
Rye, D., Wainer, B., Mesulam, M., Mufson, E., and Saper, C. (1984). Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase. Neuroscience 13, 627–643. doi: 10.1016/0306-4522(84)90083-6
Sahakian, B. J., Bruhl, A. B., Cook, J., Killikelly, C., Savulich, G., Piercy, T., et al. (2015). The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people. Philos. Trans. R. Soc. Lond. B Biol. Sci. 370, 20140214. doi: 10.1098/rstb.2014.0214
Salehi, A., Faizi, M., Colas, D., Valletta, J., Laguna, J., Takimoto-Kimura, R., et al. (2009). Restoration of norepinephrine-modulated contextual memory in a mouse model of down syndrome. Sci. Transl. Med. 1, 7ra17. doi: 10.1126/scitranslmed.3000258
Sasaki, M., Shibata, E., Tohyama, K., Takahashi, J., Otsuka, K., Tsuchiya, K., et al. (2006). Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 17, 1215–1218. doi: 10.1097/01.wnr.0000227984.84927.a7
Schouw, M., Kaag, A., Caan, M. W., Heijtel, D., Majoie, C. B., Nederveen, A. J., et al. (2013). Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI. Neuroimage 72, 1–9. doi: 10.1016/j.neuroimage.2012.12.056
Shaw, P., Sudre, G., Wharton, A., Weingart, D., Sharp, W., and Sarlls, J. (2014). White matter microstructure and the variable adult outcome of childhood attention deficit hyperactivity disorder. Neuropsychopharmacology 40, 746–754. doi: 10.1038/npp.2014.241
Shen, R., and Choong, K. (2006). Different adaptations in ventral tegmental area dopamine neurons in control and ethanol exposed rats after methylphenidate treatment. Biol. Psychiatry 59, 635–642. doi: 10.1016/j.biopsych.2005.08.021
Singh, C., Bortolato, M., Bali, N., Godar, S. C., Scott, A. L., Chen, K., et al. (2013). Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice. Proc. Natl. Acad. Sci. U.S.A. 110, 12816–12821. doi: 10.1073/pnas.1308037110
Smyser, C. D., Inder, T. E., Shimony, J. S., Hill, J. E., Degnan, A. J., Snyder, A. Z., et al. (2010). Longitudinal analysis of neural network development in preterm infants. Cereb. Cortex 20, 2852–2862. doi: 10.1093/cercor/bhq035
Solanto, M. V. (1998). Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav. Brain Res. 94, 127–152. doi: 10.1016/S0166-4328(97)00175-7
Stahl, S. M., Pradko, J. F., Haight, B. R., Modell, J. G., Rockett, C. B., and Learned-Coughlin, S. (2004). A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim. Care Companion J. Clin. Psychiatry 6, 159–166. doi: 10.4088/PCC.v06n0403
Stoehr, J. D., Mobley, S. L., Roice, D., Brooks, R., Baker, L. M., Wiley, R. G., et al. (1997). The effects of selective cholinergic basal forebrain lesions and aging upon expectancy in the rat. Neurobiol. Learn. Mem. 67, 214–227. doi: 10.1006/nlme.1997.3768
Tagliavini, F., and Pilleri, G. (1983). Basal nucleus of meynert: a neuropathological study in alzheimer's disease, simple senile dementia, pick's disease and huntington's chorea. J. Neurol. Sci. 62, 243–260. doi: 10.1016/0022-510X(83)90203-4
Tariot, P. N., Solomon, P. R., Morris, J. C., Kershaw, P., Lilienfeld, S., and Ding, C. (2000). A 5-month, randomized, placebo-controlled trial of galantamine in AD. the galantamine USA-10 study group. Neurology 54, 2269–2276. doi: 10.1212/WNL.54.12.2269
Tian, Q., Lin, Z., Wang, X., Chen, J., Wang, Q., Gong, C., et al. (2004). Injection of okadaic acid into the meynert nucleus basalis of rat brain induces decreased acetylcholine level and spatial memory deficit. Neuroscience 126, 277–284. doi: 10.1016/j.neuroscience.2004.03.037
Tomasi, D., and Volkow, N. D. (2014). Functional connectivity of substantia nigra and ventral tegmental area: maturation during adolescence and effects of ADHD. Cereb. Cortex 24, 935–944. doi: 10.1093/cercor/bhs382
Vaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., et al. (1998). Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc. Natl. Acad. Sci. U.S.A. 95, 14494–14499. doi: 10.1073/pnas.95.24.14494
Verster, J. C., Bekker, E. M., Kooij, J. S., Buitelaar, J. K., Verbaten, M. N., Volkerts, E. R., et al. (2010). Methylphenidate significantly improves declarative memory functioning of adults with ADHD. Psychopharmacology 212, 277–281. doi: 10.1007/s00213-010-1952-2
Vincent, J. L., Snyder, A. Z., Fox, M. D., Shannon, B. J., Andrews, J. R., Raichle, M. E., et al. (2006). Coherent spontaneous activity identifies a hippocampal-parietal memory network. J. Neurophysiol. 96, 3517–3531. doi: 10.1152/jn.00048.2006
Vogels, O. J. M., Broere, C. A. J., Ter Laak, H. J., Ten Donkelaar, H. J., Nieuwenhuys, R., and Schulte, B. P. M. (1990). Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol. Aging 11, 3–13. doi: 10.1016/0197-4580(90)90056-6
Volkow, N. D., Ding, Y., Fowler, J. S., Wang, G., Logan, J., Gatley, J. S., et al. (1995). Is methylphenidate like cocaine?: studies on their pharmacokinetics and distribution in the human brain. Arch. Gen. Psychiatry 52, 456–463. doi: 10.1001/archpsyc.1995.03950180042006
Volkow, N. D., Fowler, J. S., Wang, G., Ding, Y., and Gatley, S. J. (2002). Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Eur. Neuropsychopharmacol. 12, 557–566. doi: 10.1016/S0924-977X(02)00104-9
Volkow, N. D., Wang, G., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y., et al. (1998). Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am. J. Psychiatry 155, 1325–1331. doi: 10.1176/ajp.155.10.1325
Volkow, N. D., Wang, G., Fowler, J. S., Hitzemann, R., Angrist, B., Gatley, S. J., et al. (1999). Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Am. J. Psychiatry 156, 19–26. doi: 10.1176/ajp.156.1.19
Voytko, M. L., Olton, D. S., Richardson, R. T., Gorman, L. K., Tobin, J. R., and Price, D. L. (1994). Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J. Neurosci. 14, 167–186.
Warton, F. L., Howells, F. M., and Russell, V. A. (2009). Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder—lack of effect of methylphenidate. Metab. Brain Dis. 24, 599–613. doi: 10.1007/s11011-009-9166-1
Weikop, P., Yoshitake, T., and Kehr, J. (2007). Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain. Eur. Neuropsychopharmacol. 17, 658–671. doi: 10.1016/j.euroneuro.2007.02.014
Wilson, A. L., Langley, L. K., Monley, J., Bauer, T., Rottunda, S., McFalls, E., et al. (1995). Nicotine patches in alzheimer's disease: pilot study on learning, memory, and safety. Pharmacol. Biochem. Behav. 51, 509–514. doi: 10.1016/0091-3057(95)00043-V
Xia, S., Foxe, J. J., Sroubek, A. E., Branch, C., and Li, X. (2014). Topological organization of the “small-world” visual attention network in children with attention deficit/hyperactivity disorder (ADHD). Front. Human Neurosci. 8:162. doi: 10.3389/fnhum.2014.00162
Yates, C., Simpson, J., Gordon, A., Maloney, A., Allison, Y., Ritchie, I., et al. (1983). Catecholamines and cholinergic enzymes in pre-senile and senile alzheimer-type dementia and down's syndrome. Brain Res. 280, 119–126. doi: 10.1016/0006-8993(83)91179-4
Zaborsky, L., and Cullinan, W. (1996). Direct cathecholaminergic-cholinergic interactions in the basal forebram. l. dopamine-beta-hydroxylase input to cholinergic neurons. J. Comp. Neurol. 374, 5345–5554.
Zaborszky, L., Hoemke, L., Mohlberg, H., Schleicher, A., Amunts, K., and Zilles, K. (2008). Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain. Neuroimage 42, 1127–1141. doi: 10.1016/j.neuroimage.2008.05.055
Zhang, S., and Li, C. R. (2014). Functional clustering of the human inferior parietal lobule by whole-brain connectivity mapping of resting-state functional magnetic resonance imaging signals. Brain Connect. 4, 53–69. doi: 10.1089/brain.2013.0191
Zhang, S., Hu, S., Chao, H. H., and Li, C.-S. R. (2015). Resting-state functional connectivity of the locus coeruleus in humans: in comparison with the ventral tegmental area/substantia nigra pars compacta and the effects of age. Cereb. Cortex pii:bhv172. [Epub ahead of print].
Keywords: resting state connectivity, BOLD, basal forebrain, midbrain, acetylcholine, dopamine, norephinephrine
Citation: Kline RL, Zhang S, Farr OM, Hu S, Zaborszky L, Samanez-Larkin GR and Li C-SR (2016) The Effects of Methylphenidate on Resting-State Functional Connectivity of the Basal Nucleus of Meynert, Locus Coeruleus, and Ventral Tegmental Area in Healthy Adults. Front. Hum. Neurosci. 10:149. doi: 10.3389/fnhum.2016.00149
Received: 01 December 2015; Accepted: 24 March 2016;
Published: 18 April 2016.
Edited by:Joshua Oon Soo Goh, National Taiwan University, Taiwan
Reviewed by:Wei Gao, Cedars-Sinai Medical Center, USA
Mingrui Xia, Beijing Normal University, China
Copyright © 2016 Kline, Zhang, Farr, Hu, Zaborszky, Samanez-Larkin and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chiang-Shan R. Li, firstname.lastname@example.org